Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Poseida Therapeutics ( (PSTX) ) has provided an update.
Poseida Therapeutics has completed a merger where it has become a wholly owned subsidiary of a Parent company. As a result of the merger, the company has delisted its shares from Nasdaq and plans to terminate its registration and reporting obligations with the SEC. The merger agreement also led to changes in the company’s board and leadership structure.
More about Poseida Therapeutics
YTD Price Performance: 1.06%
Average Trading Volume: 1,694,304
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $931.8M
Learn more about PSTX stock on TipRanks’ Stock Analysis page.
Trending Articles
- Apple Settles $95M Class Action Suit and Clears Siri’s Privacy Norms
- Biden Plans One Last Chip Export Curb on Nvidia Before Leaving Office
- 3 Penny Stocks to Watch Now, 1/9/25
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
